IC
SRPT icon

IEQ Capital’s Sarepta Therapeutics SRPT Stock Holding History

IEQ Capital’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.37M Sell
131,822
-238,659
-64% -$4.51M 0.01% 741
2026
Q1 		$8.06M Sell
370,481
-104,523
-22% -$2.02M 0.04% 401
2025
Q4 		$10.2M Buy
475,004
+406,928
+598% +$8.58M 0.03% 338
2025
Q3 		$1.31M Buy
+68,076
New +$1.21M ﹤0.01% 913
2023
Q2 		– Sell
-1,686
Closed -$232K – 962
2023
Q1 		$232K Buy
+1,686
New +$219K 0.01% 785

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

IEQ Capital's SRPT Position: Q2 2026 in Review

IEQ Capital reduced its Sarepta Therapeutics (SRPT) stake by 64% in Q2 2026, selling an estimated $4.51M and leaving 131,822 shares worth $2.37M. The position accounts for 0.01% of the portfolio, ranked #741.

IEQ Capital first reported a position in SRPT in Q1 2023 and has held it in 5 quarters since. The position peaked at $10.2M in Q4 2025. 324 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • IEQ Capital held 131,822 shares of Sarepta Therapeutics worth $2.37M as of Q2 2026.
  • IEQ Capital sold 238,659 Sarepta Therapeutics shares in Q2 2026, an estimated $4.51M.
  • Sarepta Therapeutics made up 0.01% of IEQ Capital's portfolio in Q2 2026, its #741 holding.
  • IEQ Capital first reported a position in Sarepta Therapeutics in Q1 2023 and has held it in 5 quarters since.
  • IEQ Capital's Sarepta Therapeutics position peaked at $10.2M in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.